Exchange: NASDAQ·Updated 07:53 PM EDT
NRIX logo

NRIX Nurix Therapeutics Inc

$26.21
$0.665
(2.47%)
Today
Closed $26.21
$0.33
(1.26%)
After Hours
EarningsOct 8
Mkt Cap$2.72B
Vol929,230.00

About NRIX

Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in the business of discovering, developing, and commercializing innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases. The company was founded by John Kuriyan, Michael Rapé, and Arthur Weiss in 2009 and is headquartered in Brisbane, CA.
58

Bullish Sentiment

How do you feel about NRIX?

Advertisement|Remove ads.